EGFRvIII peptide PEPvIII acetate 是一种肿瘤特异性突变，在多形性胶质母细胞瘤 (GBM) 和其他肿瘤中广泛表达并增强致瘤性。

EGFRvIII peptide PEPvIII acetate is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and enhances tumorigenicity.

TP1589L

C72H115N19O26S

1694.86

EGFRvIII peptide PEPvIII acetate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years